Electrocardiography of the Failing Heart

Cardiology Clinics

Volumn 24, Issue 3, 2006, Pages 413-426

  Hombach, Vinzenz ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; METOPROLOL;

ACUTE CORONARY SYNDROME; ATRIOVENTRICULAR BLOCK; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; DIURESIS; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; P WAVE; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; QT INTERVAL; REVIEW; ST SEGMENT DEPRESSION; T WAVE;

EID: 33748602913     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2006.03.002     Document Type: Review

References (61)

1. Lonn E., Mathew J., Pogue J., the Heart Outcomes Prevention Evaluation Study Investigators, et al. Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Eur J Cardiovasc Prev Rehab 10 (2003) 420-428
2. Fonseca C., Oliveira A.G., Mota T., et al. The value of the electrocardiogram and chest X-ray for confirming or refuting a suspected diagnosis of heart failure in the community. Eur J Heart Fail 6 (2004) 807-812
3. Sanders P., Morton J.B., Davidson N.C., et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomical mapping in humans. Circulation 108 (2003) 1461-1468
4. Song J., Kalus J.S., Caron M.F., et al. Effect of diuresis on P-wave duration and dispersion. Pharmacotherapy 22 (2002) 564-568
5. Camsari A., Pekdemir H., Akkus M.N., et al. Long-term effects of beta blocker therapy on P-wave duration and dispersion in congestive heart failure patients: a new effect?. J Electrocardiol 36 (2003) 111-116
6. Faggiano P., Dáloia A., Zanelli E., et al. Contribution of left atrial pressure and dimension to signal-averaged P-wave duration in patients with chronic congestive heart failure. Am J Cardiol 179 (1997) 219-222
7. Yamada T., Fukunami M., Shimonagata T., et al. Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study. J Am Coll Cardiol 35 (2000) 405-413
8. Dixen U., Wallevik L., Hansen M.S., et al. Prolonged signal-averaged P wave duration as a prognostic marker for morbidity and mortality in patients with congestive heart failure. Scan Cardiovasc J 37 (2003) 193-198
9. Shamim W., Yousufuddin M., Xiao H.B., et al. Septal q waves as an indicator of risk of mortality in elderly patients with chronic heart failure. Am Heart J 44 (2002) 740-744
10. Krüger S., Filzmaier K., Graf J., et al. QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med 255 (2004) 206-212
11. Bode-Schnurbus L., Bocker D., Block M., et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 89 (2003) 1157-1162
12. Iuliano S., Fisher S.G., Karasik P.E., et al. Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 (2002) 1085-1091
13. Morgera T., Di Lenarda A., Sabbadini G., et al. Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiological findings in the nineties. Ital Heart J 5 (2004) 593-603
14. Shenkman H.J., Pampati V., Khandelwal A.K., et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest 122 (2002) 528-534
15. Shamim W., Yousufuddin M., Cicoria M., et al. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 88 (2002) 47-51
16. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
17. Nicolic G., and Marriott H.J.L. Left bundle branch block with right axis deviation: a marker of congestive cardiomyopathy. J Electrocardiol 18 (1985) 395-404
18. Childers R., Lupovich S., Sochanski M., et al. Left bundle branch block and right axis deviation: a report of 36 cases. J Electrocardiol 33 (2000) 93-102
19. Leclercq C., and Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39 (2002) 194-201
20. Leclercq C., and Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39 (2002) 194-201
21. Kass D.A. Pathology of cardiac dyssynchrony and resynchronization. In: Ellenbogen K.A., Kay G.N., and Wilkoff B.L. (Eds). Device therapy for congestive heart failure (2004), WB Saunders, Philadelphia (PA) 27-46
22. Tedrow U., Sweeney M.O., and Stevenson W.G. Physiology of cardiac resynchronization. Curr Cardiol Rep 6 (2004) 189-193
23. Vassallo J.A., Cassidy D.M., Miller J.M., et al. Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease. J Am Coll Cardiol 7 (1986) 1228-1233
24. Cazeau S., Leclercq C., Lavergne T., the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
25. Abraham W.T., Fisher W.G., Smith A.L., the MIRACLE Study Group, et al. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
26. Bristow M.R., Saxon L.A., Boehmer J., the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
27. Cleland J.G., Daubert J.C., Erdmann E., the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators, et al. The effect of cardiac resynchronization on morbidity and mortality in Heart failure. N Engl J Med 352 (2005) 1539-1549
28. Strickberger S.A., Conti J., Daoud E.G., et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 2146-2150
29. Sutton M.G., Plappert T., Hilpisch K.E., et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113 (2006) 266-272
30. Knight B.P., Desai A., Coman J., et al. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 72-77
31. Kashani A., and Barold S.S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46 (2005) 2183-2192
32. Yu C.M., Wing-Hong Fung J., Zhang Q., et al. Understanding nonresponders of cardiac resynchronization therapy-current and future perspectives. J Cardiovasc Electrophysiol 16 (2005) 1117-1124
33. Barrabes J.A., Figuears J., Moure C., et al. Q-wave evolution of a first acute myocardial infarction without significant ST segment elevation. Int J Cardiol 77 (2001) 55-62
34. Mager A., Sclarovky S., Herz I., et al. Value of the initial electrocardiogram in patients with inferior-wall acute myocardial infarction for prediction of multivessel coronary artery disease. Coron Artery Dis 11 (2000) 415-420
35. Barrabes J.A., Figueras J., Moure C., et al. Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction. Circulation 108 (2003) 814-819
36. Shah A., Wagner G.S., Granger C.B., et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol 35 (2000) 666-672
37. Hochrein J., Sun F., Pieper K.S., et al. Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. Am J Cardiol 81 (1998) 1078-1084
38. Harding J.D., Piacentino V., Gaughan J.P., et al. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 104 (2001) 1241-1247
39. Gaudron P., Kugler I., Hu K., et al. Time course of cardiac structural, functional and ellectrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol 38 (2001) 33-40
40. Vrtovec B., Delgado R., Zewail A., et al. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 107 (2003) 1764-1769
41. Berger R.D., Kasper E.K., Baughman K.L., et al. Beat-to-beat QT interval variability: novel evidence for repolraization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 96 (1997) 1557-1565
42. Grimm W., Steder U., Menz V., et al. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 78 (1996) 458-461
43. Bodi-Peris V., Monmeneu-Menadas J.V., Marin-Ortuno F., et al. QT interval dispersion in hospital patients admitted with cardiac insufficiency. Determinants and prognostic value. Rev Esp Cardiol 52 (1999) 563-569
44. Pinsky D.J., Sciacca R.R., and Steinberg J.S. QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 29 (1997) 1576-1584
45. Brooksby P., Batin P.D., Nolan J., et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom heart failure evaluation and assessment of risk trial (UK-HEART). Eur Heart J 20 (1999) 1335-1341
46. Gang Y., Ono T., Hnatkova K., et al. ELITE II investigators. QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy. Pacing Clin Electrophysiol 26 (2003) 394-400
47. Grassi G., Vailati S., Bertinieri G., et al. Heart rate as a marker of sympathetic activity. J Hypertens 16 (1998) 1635-1639
48. Fei L., Keeling P.J., Gill J.S., et al. Heart rate variability and it's relation to ventricular arrhythmias in congestive heart failure. Br Heart J 71 (1994) 322-328
49. Hoffman J., Grimm W., Menz V., et al. Heart rate variability and major arrhythmias in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 19 (1996) 1841-1844
50. Szabo B.M., van Veldhuisen D.J., van der Veer N., et al. Prognostic value of HRV in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 79 (1997) 978-980
51. Yi G., Goldman J.H., Keeling P.J., et al. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart 77 (1977) 108-114
52. Fauchier L., Babuty D., Cosnay P., et al. Heart rate variabilty in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol 30 (1997) 1009-1014
53. Aronson D., Mittleman M.A., and Burger A.J. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 93 (2004) 59-63
54. Bilchick K.C., Fetics B., Djoukeng R., et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affaiŕs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 90 (2002) 24-28
55. La Rovere M.T., Pinna G.D., Maestri R., et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 (2003) 565-570
56. Guzzetti S., La Rovere M.T., Pinna G.D., et al. Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure. Eur Heart J 26 (2005) 357-362
57. Adamson P.B., Smith A.L., Abraham W.T., the InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110 (2004) 2389-2394
58. Larsen A.I., Gjesdal K., Hall C., et al. Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability. Eur J Cardiovasc Prev Rehab 11 (2004) 162-167
59. Tambara K., Fujita M., Sumita Y., et al. Beneficial effect of candesartan treatment on cardiac autonomic nervous system activityin patients with chronic heart failure: simultaneous recording of ambulatori electrocardiogram and posture. Clin Cardiol 27 (2004) 300-303
60. De Tommasi E., Iacoviello M., Romito R., et al. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 146 (2003) E17
61. Livanis E.G., Flevari P., Theodorakis G.N., et al. Effect of biventricular pacing on heart rate variability in patients with chronic heart failure. Eur J Heart Fail 5 (2003) 175-178